窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, May 29 2025

Full Issue

Gene Delivery 'Trucks' Target Brain Cells, Hold Promise For Brain Diseases

The Washington Post reports on new tools that could lead to treatments for Parkinson's, Alzheimer's, and other neurodegenerative diseases. Other science and research news is on childhood lead exposure, a non-opioid analgesic, the "first true urban pest," and more.

Scores of researchers have produced new tools that can deliver genes and selectively activate them in hundreds of different cell types in the brain and spinal cord, a breakthrough that scientists hope advances them toward developing targeted therapies to treat neurodegenerative diseases such as ALS, Parkinsons disease and Alzheimers. The discoveries, made through the National Institutes of Healths BRAIN initiative, show with unprecedented clarity and precision how neural cells work together, but also how diseases disrupt their tight choreography. The insight offers the promise that doctors may one day treat diseases by manipulating dysfunctional cells. (Johnson, 5/28)

Academic achievement among adolescents may be affected by early childhood lead exposure at much lower levels than previously assumed, according to a new study. Just a small climb in blood concentrations of this toxic metal still within the range currently deemed acceptable by public health agencies was associated with worse performance on standardized tests, scientists found in the study, published Wednesday inEnvironmental Health. Childrens exposure to lead has long been recognized as harmful to their health and neurodevelopment, wrote the University of Iowa research team. (Udasin, 5/28)

Cancer studies

An investigational blood test for human papillomavirus (HPV)-positive oropharyngeal cancer significantly outperformed current testing methods in a direct comparison involving patient blood samples. ... The overarching goal of the research is to develop a test with sufficient sensitivity to use across multiple clinical settings and scenarios. Currently, available testing technology works well in clinical situations involving larger tumor burden, such as initial diagnosis or diagnosis of clinical relapse, but not as well in low-tumor-burden settings. (Bankhead, 5/28)

Use of the investigational non-opioid analgesic resiniferatoxin appeared to improve pain control in patients with advanced cancer who had intractable pain, though all patients experienced adverse events (AEs), according to an interim analysis of a first-in-human phase I trial. (Bassett, 5/28)

On edibles, infection control, and pests

Healthy people who regularly smoked marijuana or consumed THC-laced edibles showed signs of early cardiovascular disease similar to tobacco smokers, a new small study found. (LaMotte, 5/28)

Asurvey of Medicare-certified home healthcare (HHC) agencies reveals minor improvements and problematic declines in infection prevention and control (IPC) staff training, less frequent IPC policy reviews, and fewer agencies with intensive policies for antibiotic stewardship, intravenous (IV) and central catheter infections, and pneumonia since the height of the COVID-19 pandemic.(Van Beusekom, 5/28)

As the old saying goes, Dont let the bed bugs bite. But according to a new study, the bugs have been nipping humans since they emerged from caves around 60,000 years ago, making them possibly the first true urban pest. Evidence of our symbiotic relationship with the blood-sucking parasites could now inform predictive models for the spread of pests and diseases as cities explode in population, researchers said in the study published Wednesday in the journal Biology Letters. (Aggarwal, 5/28)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, June 5
  • Thursday, June 4
  • Wednesday, June 3
  • Tuesday, June 2
  • Monday, June 1
  • Friday, May 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF